Evidence map›Paper›PMID 25896465›Full record

ArticleBMC medicine2015

Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease.

Grace H Huynh, Daniel J Klein, Daniel P Chin, Bradley G Wagner, Philip A Eckhoff, Renzhong Liu, Lixia Wang

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 4 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 4 syntheses or guidelines pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. The rs5743708 gene polymorphism in the TLR2 gene contributes to the risk of tuberculosis disease.International journal of clinical and experimental pathology · 2015
    Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Cost-effectiveness of latent tuberculosis infection testing and treatment with 6-week regimen among key population in rural communities in China: a decision analysis study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Grace H HuynhInstitute for Disease Modeling, 1555 132nd Ave NE, Bellevue, WA, 98005, USA. ghuynh@intven.com.
Daniel J KleinInstitute for Disease Modeling, 1555 132nd Ave NE, Bellevue, WA, 98005, USA. dklein@intven.com.
Daniel P ChinChina Office, The Bill & Melinda Gates Foundation, Beijing, 100027, China. daniel.chin@gatesfoundation.org.
Bradley G WagnerInstitute for Disease Modeling, 1555 132nd Ave NE, Bellevue, WA, 98005, USA. bwagner@intven.com.
Philip A EckhoffInstitute for Disease Modeling, 1555 132nd Ave NE, Bellevue, WA, 98005, USA. peckhoff@intven.com.
Renzhong LiuChinese Center for Disease Control and Prevention, Beijing, 102206, China. sdlirenzhong@163.com.
Lixia WangChinese Center for Disease Control and Prevention, Beijing, 102206, China. wanglx@chinatb.org.
Institute for Disease Modeling · USChinese Center For Disease Control and Prevention · CNBellevue Hospital Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the last 20 years, China ramped up a DOTS (directly observed treatment, short-course)-based tuberculosis (TB) control program with 80% population coverage, achieving the 2015 Millennium Development Goal of a 50% reduction in TB prevalence and mortality. Recently, the World Health Organization developed the End TB Strategy, with an overall goal of a 90% reduction in TB incidence and a 95% reduction in TB deaths from 2015-2035. As the TB burden shifts to older individuals and China's overall population ages, it is unclear if maintaining the current DOTS strategy will be sufficient for China to reach the global targets.

methodsWe developed an individual-based computational model of TB transmission, implementing realistic age demographics and fitting to country-level data of age-dependent prevalence over time. We explored the trajectory of TB burden if the DOTS strategy is maintained or if new interventions are introduced using currently available and soon-to-be-available tools. These interventions include increasing population coverage of DOTS, reducing time to treatment, increasing treatment success, and active case finding among elders > 65 years old. We also considered preventative therapy in latently infected elders, a strategy limited by resource constraints and the risk of adverse events.

resultsMaintenance of the DOTS strategy reduces TB incidence and mortality by 42% (95% credible interval, 27-59%) and 41% (5-64%), respectively, between 2015 and 2035. A combination of all feasible interventions nears the 2035 mortality target, reducing TB incidence and mortality by 59% (50-76%) and 83% (73-94%). Addition of preventative therapy for elders would enable China to nearly reach both the incidence and mortality targets, reducing incidence and mortality by 84% (78-93%) and 92% (86-98%).

conclusionsThe current decline in incidence is driven by two factors: maintaining a low level of new infections in young individuals and the aging out of older latently infected individuals who contribute incidence due to reactivation disease. While further reducing the level of new infections has a modest effect on burden, interventions that limit reactivation have a greater impact on TB burden. Tools that make preventative therapy more feasible on a large scale and in elders will help China achieve the global targets.

Indexed as

AdolescentAdultAgedChinaDirectly Observed TherapyFemaleHumansIncidenceMaleMiddle AgedModels, TheoreticalPrevalenceTreatment OutcomeTuberculosisWorld Health OrganizationYoung Adult

Identifiers

PMID25896465
PMCPMC4424583
OpenAlexW1967685939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.